These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34509104)

  • 21. Physical Activity, Positive and Negative Symptoms of Psychosis, and General Psychopathology among People with Psychotic Disorders: A Meta-Analysis.
    Swora E; Boberska M; Kulis E; Knoll N; Keller J; Luszczynska A
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis.
    Firth J; Carney R; Stubbs B; Teasdale SB; Vancampfort D; Ward PB; Berk M; Sarris J
    Schizophr Bull; 2018 Oct; 44(6):1275-1292. PubMed ID: 29206972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical symptoms of psychotic episodes and 25-hydroxy vitamin D serum levels in black first-generation immigrants.
    Dealberto MJ
    Acta Psychiatr Scand; 2013 Dec; 128(6):475-87. PubMed ID: 23405850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    Abdin E; Chong SA; Vaingankar JA; Peh CX; Poon LY; Rao S; Verma S; Subramaniam M
    PLoS One; 2017; 12(11):e0187141. PubMed ID: 29095875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
    Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
    Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
    Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurophysiological Correlate of Emotion Regulation by Cognitive Reappraisal and Its Association With Psychotic Symptoms in Early Psychosis.
    Kim M; Hwang WJ; Park J; Kim T; Oh S; Kwon JS
    Schizophr Bull; 2021 Jan; 47(1):87-96. PubMed ID: 32609340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity.
    van der Leeuw C; de Witte LD; Stellinga A; van der Ley C; Bruggeman R; Kahn RS; van Os J; Marcelis M;
    Psychol Med; 2020 Jul; 50(10):1680-1686. PubMed ID: 31327333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of vitamin D deficiency in established psychosis.
    Lally J; Gardner-Sood P; Firdosi M; Iyegbe C; Stubbs B; Greenwood K; Murray R; Smith S; Howes O; Gaughran F
    BMC Psychiatry; 2016 Mar; 16():76. PubMed ID: 27000113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition.
    Barnard K; Colón-Emeric C
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):4-33. PubMed ID: 20226390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review: the relationship between sleep spindle activity with cognitive functions, positive and negative symptoms in psychosis.
    Au CH; Harvey CJ
    Sleep Med X; 2020 Dec; 2():100025. PubMed ID: 33870177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post-traumatic stress disorder in reaction to psychotic experience: A systematic revue].
    Galliot G; Very E; Schmitt L; Rouch V; Salles J
    Encephale; 2019 Dec; 45(6):506-512. PubMed ID: 31521338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders.
    Bruins J; Jörg F; van den Heuvel ER; Bartels-Velthuis AA; Corpeleijn E; Muskiet FAJ; Pijnenborg GHM; Bruggeman R
    Schizophr Res; 2018 May; 195():513-518. PubMed ID: 28927862
    [No Abstract]   [Full Text] [Related]  

  • 34. The association between cognitive deficits and depressive symptoms in at-risk mental state: a comparison with first-episode psychosis.
    Ohmuro N; Matsumoto K; Katsura M; Obara C; Kikuchi T; Hamaie Y; Sakuma A; Iizuka K; Ito F; Matsuoka H
    Schizophr Res; 2015 Mar; 162(1-3):67-73. PubMed ID: 25618299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression.
    Herniman SE; Allott K; Phillips LJ; Wood SJ; Uren J; Mallawaarachchi SR; Cotton SM
    Psychol Med; 2019 Nov; 49(15):2463-2474. PubMed ID: 31524121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Vitamin D Status and Schizophrenia: A First Psychotic Episode Study.
    Salavert J; Grados D; Ramiro N; Carrión MI; Fadeuilhe C; Palma F; López L; Erra A; Ramírez N
    J Nerv Ment Dis; 2017 May; 205(5):409-412. PubMed ID: 28406840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Krivoy A; Onn R; Vilner Y; Hochman E; Weizman S; Paz A; Hess S; Sagy R; Kimhi-Nesher S; Kalter E; Friedman T; Friedman Z; Bormant G; Trommer S; Valevski A; Weizman A
    EBioMedicine; 2017 Dec; 26():138-145. PubMed ID: 29226809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social cognitive performance as a marker of positive psychotic symptoms in young people seeking help for mental health problems.
    Guastella AJ; Hermens DF; Van Zwieten A; Naismith SL; Lee RS; Cacciotti-Saija C; Scott EM; Hickie IB
    Schizophr Res; 2013 Sep; 149(1-3):77-82. PubMed ID: 23845388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
    Berger M; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Mitchell TW; Meyer BJ; Thompson A; Yung AR; McGorry PD; Amminger GP
    Front Psychiatry; 2019; 10():393. PubMed ID: 31244693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.